2020 annual financial data

Relmada Therapeutics 2020 Net margin

Relmada Therapeutics 2020 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -60,838,673 USD and net income was -59,456,394 USD.
Operating cash flow was -27,808,801 USD.

Get free Relmada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-60,838,673 USD
Net income
-59,456,394 USD
Operating cash flow
-27,808,801 USD